Boston Scientific

42°21′37.3″N 71°33′32.6″W Boston Scientific Corporation ("BSC"), incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).

Boston Scientific Corporation
Company typePublic
Traded as
  • NYSE: BSX
  • S&P 500 component
ISINUS1011371077
IndustryMedical device
FoundedJune 29, 1979 (1979-06-29) in Watertown, Massachusetts
Founders
HeadquartersMarlborough, Massachusetts, U.S.
Key people
Revenue US$14.24 billion (2023)
US$2.343 billion (2023)
Net income
US$1.592 billion (2023)
Total assets US$35.14 billion (2023)
Total equity US$19.28 billion (2023)
Number of employees
c.48,000 (2023)
Websitebostonscientific.com
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.